Zai Lab (ZLAB) Non-Current Deffered Revenue (2016 - 2026)

Zai Lab (ZLAB) posted quarterly Non-Current Deffered Revenue of $28.6 million for Q1 2026, down 4.98% year-on-year from $30.1 million in Q1 2025, and up 4.73% on a QoQ basis from $27.3 million in Q4 2025.

Zai Lab (ZLAB) Non-Current Deffered Revenue (2016 - 2026) Analysis & Trends

Zai Lab (ZLAB) has reported Non-Current Deffered Revenue for 8 consecutive years, with $28.6 million the latest figure, recorded in Q1 2026.

  • Quarterly Non-Current Deffered Revenue fell 4.98% year-over-year to $28.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $28.6 million (down 4.98% YoY) and the FY2025 annual result came in at $27.3 million, down 13.04% from the prior year.
  • Non-Current Deffered Revenue rose to $28.6 million in Q1 2026 per ZLAB's latest filing, from $27.3 million in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for ZLAB reached as high as $31.4 million in Q4 2024 and fell as low as $21.4 million in Q4 2022.
  • A 5-year average of $27.3 million and a median of $27.9 million in 2023 frame the typical range for Non-Current Deffered Revenue.
  • Annual changes were most pronounced in 2022 — Non-Current Deffered Revenue decreased 22.29% — and 2023, when it soared 34.54%.
  • Year by year, Non-Current Deffered Revenue stood at $21.4 million in 2022, then surged by 34.54% to $28.7 million in 2023, then rose by 9.38% to $31.4 million in 2024, then retreated by 13.04% to $27.3 million in 2025, then advanced by 4.73% to $28.6 million in 2026.
  • According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $28.6 million, $27.3 million, and $28.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 225.10 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Zai Lab 22.02 Bn 22.02 Bn 61.30 Mn 28.63 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 28.63 Mn
Dec 31, 2025 27.33 Mn
Sep 30, 2025 28.06 Mn
Jun 30, 2025 29.23 Mn
Mar 31, 2025 30.13 Mn
Dec 31, 2024 31.43 Mn
Sep 30, 2024 24.92 Mn
Jun 30, 2024 25.34 Mn
Mar 31, 2024 26.30 Mn
Dec 31, 2023 28.74 Mn
Sep 30, 2023 27.69 Mn
Jun 30, 2023 28.63 Mn
Mar 31, 2023 30.97 Mn
Dec 31, 2022 21.36 Mn
Sep 30, 2022 23.21 Mn
Jun 30, 2022 24.78 Mn
Dec 31, 2021 27.49 Mn
Dec 31, 2017 2.39 Mn
Dec 31, 2016 778,434.00